Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level

Journal of Neuroscience

Volumn 19, Issue 23, 1999, Pages 10494-10501

  Benmansour, Saloua ^a,d   Cecchi, Marco ^a   Morilak, David A ^a   Gerhardt, Greg A ^c   Javors, Martin A ^a   Gould, Georgianna G ^a   Frazer, Alan ^a,b  

^a University of Texas Health Science Center   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Antidepressants; Dorsal hippocampus; In vivo electrochemistry; mRNA for the SERT; Serotonin transporter; 3H CN IMI binding

Indexed keywords

ANTIDEPRESSANT AGENT; CIANOPRAMINE; DESIPRAMINE; MESSENGER RNA; PAROXETINE; PHENELZINE; SEROTONIN TRANSPORTER; SERTRALINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG EFFECT; ELECTROCHEMISTRY; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAPHE NUCLEUS; RAT; RECEPTOR DENSITY; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM;

EID: 0033507575     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-23-10494.1999     Document Type: Article

References (42)

1. Auerbach SB, Hjorth S (1995) Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitors citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo. Naunyn Schmiedebergs Arch Pharmacol 352:597-606.
2. Blakely RD, Ramamoorthy S, Qian Y, Schroeter S, Bradley CC (1997) Regulation of antidepressant-sensitive serotonin transporters. In: Neurotransmitter transporters. Structure, function and regulation (Reith MEA, ed), pp 29-72. Totowa, NJ: Humana.
3. Blier P, Bouchard C (1994) Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs. Br J Pharmacol 113:485-495.
4. 3H]imipramine binding and serotonin uptake in rat cerebral cortex after prolonged treatment. Fundam Clin Pharmacol 1:327-333.
5. Burnet PWJ, Michelson D, Smith MA, Gold PW, Sternberg EM (1994) The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptor and the abundancies of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of tree strain of rats. Brain Res 638:311-324.
6. Byrne SE, Rothschild AJ (1998) Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments. J Clin Psychiatry 59:279-288.
7. 3H]5-HT uptake: effect of administration of various antidepressant treatments. Neuropharmacology 32:737-743.
8. Daws LC, Toney GM, Gerhardt GA, Frazer (1998) In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters. J Pharmacol Exp Ther 286:967-976.
9. 1A adrenergic receptor mRNA in the rat brain visualized by In situ hybridization. J Comp Neurol 386:358-378.
10. Frazer A (1997) Pharmacology of antidepressants. J Clin Psychopharmacol 17:2S-18S.
11. Frazer A, Morilak DA (1998) Drugs for the treatment of affective (Mood) disorders. In: Human pharmacology. Molecular to clinical (Brody TM, Lamer J, Minneman KP, eds), pp 349-362. New York: Mosby.
12. Gerhardt GA, Oke AF, Nagy G, Moghaddam B, Adams RN (1984) Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res 290:390-394.
13. Gobbi M, Crespi D, Foddi MC, Fracasso C, Mancini L, Parotti L, Mennini T (1997) Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats. Naunyn Schmiedebergs Arch Pharmacol 356:22-28.
14. Hall ME, Hoffer BJ, Gerhardt GA (1989) Rapid and sensitive determination of catecholamines in small tissue samples by high performance liquid chromatography coupled with dual-electrode coulometric electrochemical detection. Liquid Chromatography/Gas Chromatography 7:258-265.
15. Hensler JG, Ferry RC, Labow DM, Kovachich GB, Frazer A (1994) Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from the dorsal raphe nucleus. Synapse 17:1-15.
16. Hrdina PD, Vu TB (1993) Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study. Synapse 14:324-331.
17. Hyttel J, Overo KF, Arnt J (1984) Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT uptake inhibitor, citalopram. Psychopharmacology 83:20-27.
18. Kaye CM, Haddock RE, Langley PF, Mellows G, Tasker TC, Zussman BD, Greb WH (1989) A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatr Scand 80:60-75.
19. Koed K, Linnet K (1997) The serotonin transporter messenger RNA level in the rat brain is not regulated by antidepressants. Biol Psychiatry 42:1177-1180.
20. 3H]cyanoimipramine. Brain Res 454:78-88.
21. Kovachich GB, Aronson CE, Brunswick DJ (1992) Effect of repeated administration of antidepressants on serotonin uptake sites in limbic and neocortical structures of rat brain determined by quantitative autoradiography. Neuropsychopharmacology 7:317-324.
22. Kuroda Y, Watanabe Y, McEwen BS (1994) Tianeptine decreases both serotonin transporter mRNA and binding sites in rat brain. Eur J Pharmacol Mol Pharmacol 268:R3-R5.
23. Lesch PK, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL, Murphy DL (1993) Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Mol Brain Res 17:31-35.
24. Linnet K, Koed K, Wiborg O, Gregersen N (1995) Serotonin depletion decreases serotonin transporter mRNA levels in rat brain. Brain Res 697:251-253.
25. Lopez JF, Chalmers DT, Vazquez DM, Watson SJ, Akil H (1994) Serotonin transporter mRNA in rat brain is regulated by classical antidepressants. Biol Psychiatry 35:287-290.
26. Marcusson JO, Ross SB (1990) Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets. Psychopharmacology (Berl) 102:145-155.
27. Mongeau R, de Montigny C, Blier P (1994) Electrophysiologic evidence for desensitization of α2-adrenoceptors on serotonin terminals following long term treatment with drugs increasing norepinephrine synaptic concentration. Neuropsychopharmacology 10:41-51.
28. Neumaier JF, Root DC, Hamblin MW (1996) Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal Raphe nucleus. Neuropsychopharmacology 15:515-522.
29. Paxinos G, Watson C (1986) The rat brain in strereotaxic coordinates. New York: Academic.
30. Piñeyro G, Blier P, Dennis T, de Montigny C (1994) Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci 14:3036-3047.
31. 2+/calmodulin-dependent protein kinase II: autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake. Mol Pharmacol 48:623-629.
32. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD (1997) Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci 17:45-57.
33. Ramamoorthy S, Blakely RD (1999) Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285:763-766.
34. Ramamoorthy S, Giovanetti E, Qian Y, Blakely RD (1998) Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J Biol Chem 273:2458-2466.
35. Rattray M, Baldessari S, Gobbi M, Mennini T, Samanin R, Bendotti C (1996) p-Chlorophenylalanine changes serotonin transporter mRNA levels and expression of the gene product. J Neurochem 67:463-472.
36. Spurlock G, Buckland P, O'Donovan M, McGuffin P (1994) Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter. Neuropharmacology 33:433-440.
37. Swan MC, Rahman Najlerahim A, Bennet JP (1997) Expression of serotonin transporter mRNA in rat brain: presence in neuronal and nonneuronal cells and effect of paroxetine. J Chem Neuroanat 13:71-76.
38. Thase ME, Rush JA (1997) When at first you don't succeed: sequential strategics for antidepressant nonresponders. J Clin Psychiatry 58:23-29.
39. Thase ME, Blomgren SL, Birkett MA, Apter JT, Tepner RG (1997) Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline. J Clin Psychiatry 58:16-21.
40. Tulloch IF, Johnson AM (1992) The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor. J Clin Psychiatry 53:7-12.
41. Watanabe Y, Sakai RR, McEwen BS, Mendelson S (1993) Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin. Brain Res 615:87-94.
42. Yeghiayan SK, Andersen SL, Baldessarini RJ (1997) Lack of effect of chronic clorgyline or selegiline on dopamine and serotonin transporters in rat caudate-putamen or nucleus accumbens septi. Neurosci Lett 236:147-150.